epigallocatechin gallate has been researched along with Rhynchophylline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, L; Cao, Z; Ding, G; Ding, Y; Ke, Z; Liu, H; Su, Z; Wang, Z; Xiao, W; Zhang, X | 1 |
| Blanch, EW; Dahdah, A; de Silva, NH; Hügel, HM; Maniam, S | 1 |
2 other study(ies) available for epigallocatechin gallate and Rhynchophylline
| Article | Year |
|---|---|
Discovery of a potent angiotensin converting enzyme inhibitor via virtual screening.
Topics: Angiotensin-Converting Enzyme Inhibitors; Binding Sites; Catechin; Chalcones; Drug Evaluation, Preclinical; Humans; Molecular Docking Simulation; Peptidyl-Dipeptidase A; Protein Binding; Protein Structure, Tertiary; Pyrrolizidine Alkaloids | 2017 |
Regioselective pyrrolizidine bis-spirooxindoles as efficient anti-amyloidogenic agents.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Blood-Brain Barrier; Cycloaddition Reaction; Humans | 2022 |